drugset
drugset / Trial / NCT04768478

CBD for Pain Reduction and Opioid Use After Ankle and Tibia Fracture ORIF

NCT04768478 ↗

Phase 4 Withdrawn NYU Langone Health
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the effects of administering CBD to control post-operative pain in patients undergoing ankle fracture open reduction and internal fixation, tibial plafond (pilon) open reduction and internal fixation, tibial shaft repair (open reduction internal fixation or intramedullary nail fixation), or tibial plateau open reduction and internal fixation. Secondly, the purpose is to evaluate the effectiveness of CBD in comparison with opioid therapy for post-operative pain.

Timeline

Start
2021-10-01
Primary completion
2023-10-01
Completion
2023-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cannabidiol Other / unclassified 50 mg Oral

Indications

No indication recorded.